D
AbCellera Biologics Inc. ABCL
$4.39 $0.092.09% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -0.54% -35.41% -24.17% -34.59% -77.23%
Total Other Revenue -- -- -- -- --
Total Revenue -0.54% -35.41% -24.17% -34.59% -77.23%
Cost of Revenue 1.20% 5.03% -4.78% 8.27% 3.87%
Gross Profit -1.63% -16.47% -0.58% -28.56% -770.43%
SG&A Expenses 1.91% 8.90% 13.72% 18.93% 14.26%
Depreciation & Amortization -48.23% 150.10% 141.24% 285.24% 151.88%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -7.54% 19.25% 13.21% 35.91% 19.47%
Operating Income 8.40% -27.86% -19.21% -53.62% -149.56%
Income Before Tax -11.17% -24.91% -15.15% -28.90% -151.93%
Income Tax Expenses -29.84% -96.79% -35.85% 4.79% -970.72%
Earnings from Continuing Operations -8.07% -14.28% -11.24% -36.13% -107.42%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -8.07% -14.28% -11.24% -36.13% -107.42%
EBIT 8.40% -27.86% -19.21% -53.62% -149.56%
EBITDA 14.17% 3.17% 10.83% -24.66% -148.92%
EPS Basic -6.32% -12.30% -9.28% -33.82% -105.07%
Normalized Basic EPS -4.98% -17.49% -8.45% -53.27% -211.93%
EPS Diluted -4.17% -10.10% -7.56% -34.93% -96.72%
Normalized Diluted EPS -4.98% -17.49% -8.45% -53.27% -189.78%
Average Basic Shares Outstanding 1.69% 1.79% 1.79% 1.71% 1.62%
Average Diluted Shares Outstanding 1.69% 1.79% 1.79% 1.71% -1.01%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --